Showing results (1941-1950 of 2,113) with videos related to
Sort By:
Pageof 212
The British Journal of Ophthalmology|July 10, 2021
Deep learning algorithms for automatic detection of pterygium using anterior segment photographs from slit-lamp and hand-held camerasXiaoling Fang, Mihir Deshmukh, Miao Li Chee, et al.Frontiers in Bioengineering and Biotechnology|October 6, 2025
Evaluation of <i>in vitro</i> and <i>in vivo</i> release of recombinant human nerve growth factor from bioengineered human stromal lenticuleMolly Tzu-Yu Lin, Yu-Chi Liu, Isabelle Xin Yu Lee, et al.Haematologica|April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adultsRohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.Cardiology in Review|February 17, 2022
Robotic Assisted Versus Manual Percutaneous Coronary Intervention: Systematic Review and Meta-AnalysisRahul Gupta, Aaqib H Malik, Jeffrey Shi Kai Chan, et al.Circulation|September 12, 2012
Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatmentAshish K Sharma, Guanyi Lu, Andrea Jester, et al.HIV Medicine|October 11, 2021
Long-term outcomes for children and adolescents with Kaposi sarcomaAllison Silverstein, William Kamiyango, Jimmy Villiera, et al.Scientific Reports|May 6, 2020
Phenotypic and functional characterization of corneal endothelial cells during in vitro expansionRicardo F Frausto, Vinay S Swamy, Gary S L Peh, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 17, 2023
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)Mattias Bergqvist, Adrian Nordmark, Amy Williams, et al.The Ocular Surface|April 22, 2023
TFOS Lifestyle: Impact of elective medications and procedures on the ocular surfaceJosé Alvaro P Gomes, Dimitri T Azar, Christophe Baudouin, et al.Clinical Lymphoma, Myeloma & Leukemia|June 16, 2019
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell LeukemiaSamer Tabchi, Rajit Nair, Chutima Kunacheewa, et al.Pageof 212